{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:20:26Z","timestamp":1773112826710,"version":"3.50.1"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Rep"],"DOI":"10.3892\/mmr.2020.11533","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T06:19:09Z","timestamp":1600841949000},"source":"Crossref","is-referenced-by-count":7,"title":["Hypoxia in\ufffdutero increases the risk of pulmonary hypertension in rat offspring and is associated with vasopressin type\u20112 receptor upregulation"],"prefix":"10.3892","author":[{"given":"Hao","family":"Ding","sequence":"first","affiliation":[{"name":"Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaying","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqing","family":"Xiong","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Disease, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"key20201006121248_b1-mmr-22-05-4173","first-page":"63","article-title":"Persistent pulmonary hypertension in the newborn","volume":"4","author":"Mathew","year":"2017","journal-title":"Children (Basel)"},{"key":"key20201006121248_b2-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/JCI105355","article-title":"Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes","volume":"45","author":"Rudolph","year":"1966","journal-title":"J Clin Invest"},{"key":"key20201006121248_b3-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.freeradbiomed.2012.02.041","article-title":"Reactive oxygen and nitrogen species in pulmonary hypertension","volume":"52","author":"Tabima","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"key20201006121248_b4-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT)","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"key20201006121248_b5-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20201006121248_b6-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00392-014-0765-4","article-title":"Pulmonary hypertension 2015: Current definitions, terminology, and novel treatment options","volume":"104","author":"Rosenkranz","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"key20201006121248_b7-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/2045-8932.94818","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"2","author":"Delaney","year":"2012","journal-title":"Pulm Circ"},{"key":"key20201006121248_b8-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.acvd.2012.12.005","article-title":"Pathophysiology of persistent pulmonary hypertension of the newborn: Impact of the perinatal environment","volume":"106","author":"Storme","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"key20201006121248_b9-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1097\/HJH.0b013e32833e08f1","article-title":"Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat","volume":"28","author":"Xu","year":"2010","journal-title":"J Hypertens"},{"key":"key20201006121248_b10-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3892\/ijmm.2016.2773","article-title":"Suppression of the expression of hypoxia-inducible factor-1alpha by RNA interference alleviates hypoxia-induced pulmonary hypertension in adult rats","volume":"38","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"key20201006121248_b11-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"L86","DOI":"10.1152\/ajplung.00534.2007","article-title":"Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung","volume":"295","author":"Ambalavanan","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key20201006121248_b12-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0300060515589394","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension","volume":"43","author":"\u00d6zpelit","year":"2015","journal-title":"J Int Med Res"},{"key":"key20201006121248_b13-mmr-22-05-4173","first-page":"207","article-title":"Angiogenin, bFGF and VEGF: angiogenic markers in breath condensate of patients with pulmonary hypertension","volume":"69","author":"Seyfarth","year":"2015","journal-title":"Pneumologie"},{"key":"key20201006121248_b14-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4137\/BMI.S38323","article-title":"Role of biomarkers in the diagnosis, risk assessment, and management of pulmonary hypertension","volume":"11","author":"Rameh","year":"2016","journal-title":"Biomark Insights"},{"key":"key20201006121248_b15-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"e18041","DOI":"10.1371\/journal.pone.0018041","article-title":"Soluble flt-1 and PlGF: New markers of early pregnancy loss?","volume":"6","author":"Muttukrishna","year":"2011","journal-title":"PLoS One"},{"key":"key20201006121248_b16-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijdevneu.2014.08.003","article-title":"Impaired cerebral angiogenesis in the fetal lamb model of persistent pulmonary hypertension","volume":"38","author":"Cohen","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"key20201006121248_b17-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/14767058.2010.482608","article-title":"Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin","volume":"24","author":"Xu","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key20201006121248_b18-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0022-3476(76)80021-2","article-title":"Persistent fetal circulation: Newly recognized structural features","volume":"88","author":"Haworth","year":"1976","journal-title":"J Pediatr"},{"key":"key20201006121248_b19-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"133S","DOI":"10.1378\/chest.93.3_Supplement.133S","article-title":"Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art","volume":"93","author":"Haworth","year":"1988","journal-title":"Chest"},{"key":"key20201006121248_b20-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.tips.2017.03.003","article-title":"Targeting the prostacyclin pathway: Beyond pulmonary arterial hypertension","volume":"38","author":"Pluchart","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"key20201006121248_b21-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1253\/circj.CJ-15-1175","article-title":"Detrimental impact of vasopressin V2 receptor antagonism in a su5416\/hypoxia\/normoxia-exposed rat model of pulmonary arterial hypertension","volume":"80","author":"Goto","year":"2016","journal-title":"Circul J"},{"key":"key20201006121248_b22-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/FJC.0000000000000300","article-title":"Effects of long-term blockade of vasopressin receptor types 1a and 2 on cardiac and renal damage in a rat model of hypertensive heart failure","volume":"66","author":"Ikeda","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"key20201006121248_b23-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bpa.2010.02.021","article-title":"Pulmonary hypertension of the newborn","volume":"24","author":"Stayer","year":"2010","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"key20201006121248_b24-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jfma.2012.11.007","article-title":"Persistent pulmonary hypertension of the newborn","volume":"112","author":"Teng","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"key20201006121248_b25-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"858154","DOI":"10.1155\/2011\/858154","article-title":"Patient characteristics in persistent pulmonary hypertension of the newborn","volume":"2011","author":"Roofthooft","year":"2011","journal-title":"Pulm Med"},{"key":"key20201006121248_b26-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/152702903322022820","article-title":"Cardiopulmonary transition in the high altitude infant","volume":"4","author":"Niermeyer","year":"2003","journal-title":"High Alt Med Biol"},{"key":"key20201006121248_b27-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/ham.2007.1068","article-title":"Going to high altitude with a newborn infant","volume":"8","author":"Niermeyer","year":"2007","journal-title":"High Alt Med Biol"},{"key":"key20201006121248_b28-mmr-22-05-4173","article-title":"Guidance on the Care of Laboratory Animals: (2006) No. 398, Ministry of Science and Technology","year":"2006"},{"key":"key20201006121248_b29-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"H1321","DOI":"10.1152\/ajpheart.00440.2008","article-title":"Hypoxia during pregnancy in rats leads to early morphological changes of atherosclerosis in adult offspring","volume":"296","author":"Wang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20201006121248_b30-mmr-22-05-4173","article-title":"Euthanasia of animals used in science, 2010","author":"Canadian Council on Animal Care. CCAC guidelines on"},{"key":"key20201006121248_b31-mmr-22-05-4173","article-title":"Albert Einstein College of Medicine Institute for Animal Studies. Recommended Methods of Anesthesia, Analgesia, and Euthanasia for Laboratory Animal Species","year":"2014"},{"key":"key20201006121248_b32-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20201006121248_b33-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2017.00011","article-title":"Peptide agonists of vasopressin V2 receptor reduce expression of neuroendocrine markers and tumor growth in human lung and prostate tumor cells","volume":"7","author":"Pifano","year":"2017","journal-title":"Front Oncol"},{"key":"key20201006121248_b34-mmr-22-05-4173","first-page":"5049","article-title":"Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer","volume":"30","author":"Ripoll","year":"2010","journal-title":"Anticancer Res"},{"key":"key20201006121248_b35-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCHEARTFAILURE.111.965392","article-title":"Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure","volume":"5","author":"Morooka","year":"2012","journal-title":"Circ Heart Fail"},{"key":"key20201006121248_b36-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/CIRCHEARTFAILURE.112.968750","article-title":"Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats","volume":"5","author":"Yamazaki","year":"2012","journal-title":"Circ Heart Fail"},{"key":"key20201006121248_b37-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1183\/09031936.00044915","article-title":"Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension","volume":"46","author":"Tamura","year":"2015","journal-title":"Eur Respir J"},{"key":"key20201006121248_b38-mmr-22-05-4173","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jccase.2014.02.003","article-title":"Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy","volume":"9","author":"Joko","year":"2014","journal-title":"J Cardiol Cases"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T09:13:42Z","timestamp":1601975622000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2020.11533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/mmr.2020.11533","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]}}}